
Granules India’s Bonthapally API Facility Receives US FDA EIR With VAI Classification
Hyderabad: Granules India Limited, a prominent pharmaceutical manufacturer, has announced the successful receipt of an Establishment Inspection Report (EIR) from the U.S. Food













